Delivery of foreign cytotoxic T lymphocyte epitopes to tumor tissues for effective antitumor immunotherapy against pre-established solid tumors in mice

MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice

(2016) Vani Lakshminarayanan et al.   PLoS One

Peptide therapeutics: current status and future directions

(2015) Keld Fosgerau et al.   DRUG DISCOVERY TODAY

A polymeric conjugate foreignizing tumor cells for targeted immunotherapy in vivo

(2015) Young-Ho Lee et al.   JOURNAL OF CONTROLLED RELEASE

Nanoparticle-Based Immunotherapy for Cancer

(2014) Kun Shao et al.   ACS Nano

Treatment of Experimental Autoimmune Encephalomyelitis by Codelivery of Disease Associated Peptide and Dexamethasone in Acetalated Dextran Microparticles

(2014) Kevin J. Peine et al.   MOLECULAR PHARMACEUTICS

Therapeutic vaccines for cancer: an overview of clinical trials

(2014) Ignacio Melero et al.   Nature Reviews Clinical Oncology

Cancer immunotherapy using a potent immunodominant CTL epitope

(2014) Liwen Song et al.   VACCINE

Tunable Protein Release from Acetalated Dextran Microparticles: A Platform for Delivery of Protein Therapeutics to the Heart Post-MI

(2013) Sophia Suarez et al.   BIOMACROMOLECULES

Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology

(2013) U. Prabhakar et al.   CANCER RESEARCH

Control of spontaneous ovarian tumors by CD8+ T cells through NKG2D-targeted delivery of antigenic peptide

(2013) Tae Kang et al.   Cell and Bioscience

Promiscuous binding of extracellular peptides to cell surface class I MHC protein

(2012) H. N. Eisen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Acetal-Modified Dextran Microparticles with Controlled Degradation Kinetics and Surface Functionality for Gene Delivery in Phagocytic and Non-Phagocytic Cells

(2010) Joel A. Cohen et al.   ADVANCED MATERIALS

A novel immunotherapeutic approach to melanoma-bearing hosts with protein-transduction domain-containing immunogenic foreign antigens

(2010) Mirei Kanzaki et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Bystander killing of cancer requires the cooperation of CD4+and CD8+T cells during the effector phase

(2010) Andrea Schietinger et al.   JOURNAL OF EXPERIMENTAL MEDICINE

pH-Responsive Nanoparticles for Drug Delivery

(2010) Weiwei Gao et al.   MOLECULAR PHARMACEUTICS

Antigen Specific In Vivo Killing Assay using CFSE Labeled Target Cells

(2010) Marina Durward et al.   Jove-Journal of Visualized Experiments

Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect

(2008) H. Maeda et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice

(2008) Béatrice Breart et al.   JOURNAL OF CLINICAL INVESTIGATION

Acetal-Derivatized Dextran: An Acid-Responsive Biodegradable Material for Therapeutic Applications

(2008) Eric M. Bachelder et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY